WednesdayJune 3, 201509:00
SaturdayJune 6, 201517:00
BioGaia exhibited its oral health probiotic BioGaia ProDentis at the Europerio8 Congress in London, UK, 3-6 June 2015.
Around 8000 dental professionals attended EuroPerio8, a congress that has established itself as the world’s leading conference in periodontology and implant dentistry.
Although many dental professionals still have limited experience with oral health probiotics the interest in BioGaia’s clinically documented Lactobacillus reuteri Prodentis was greater than expected.
In the booth two products were exhibited, BioGaia ProDentis drops, for professional use chair-side, and BioGaia ProDentis lozenges, for consumer use at home. Both products contain Lactobacillus reuteri Prodentis, which is the most well documented oral health probiotic with more than 20 clinical studies in patients with periodontitis and gingivitis.
About Lactobacillus reuteri Prodentis
Oral probiotics offer a new line of therapy to support existing and well-proven mechanical removal of plaque biofilm by influencing the periodontal microbiota. Lactobacillus reuteri Prodentis has proven efficacy and safety through more than ten clinical trials. It is the patented combination of two complementary strains, Lactobacillus reuteri DSM 17938 andLactobacillus reuteri ATCC PTA 5289, specifically selected for their exclusive synergistic properties in reducing plaque, gingivitis and periodontitis.